Logo
M

Medinno

3 employees

Medinno develops cell therapeutics for brain diseases.

Basic info

Industry

biotechnology research

Sectors

Neural stem cell
Therapeutics
Spinal cord injury
Brain tumor
Intraventricular hemorrhage
Hypoxic ischemic encephalopathy
Mesenchymal stem cell
Cell Therapy
Stroke
Gene therapy
Health Care

Date founded

2018

Funding rounds raised

M

Medinno raised undisclosed on January 1, 2019

Investors: Company K Partners

FAQ